Epigenomics-cancer-screening-blood-test-were-appritiated-by-FDA
Epigenomics' cancer screening blood test were appritiated by FDA
Colorectal cancer screening system of Epigenomic was appriciated by FDA. The America-baseddiagnostic company was however provided with some good advices to develop the system....
Tags: blood test, colorectar cancer, cancer, cancer diagnosys, FDA...
April 2, 2014
Transgene-increases-its-profit-with-captial-replacement
Transgene increases its profit with captial replacement
Transgene is a pharmaceutical company, based in Paris, France. It foucese on development of genetic treatments. The company announced a two-step capital replacement, which increases its issues by 65,5 Euros....
Tags: transgene, euros, captial replacement, stock exchange...
March 25, 2014
MMV-and-Merck-Serono-are-ciollaborating-on-findig-anti-malaria-drug
MMV and Merck Serono are ciollaborating on findig anti malaria drug
MMC and Marck Serono set up a group which is working on a chemical series that has shown significant antimalarial potential. The series has a unique profile as the compounds are long-acting and have demonstrated high potency in in vitro and in vivo preclinical malaria m...
Tags: in vitro, malaria drug, Merck, MMV, malaaria...
March 20, 2014
Immun-oncology-therapies-are-going-to-be-commerzialized-and-sitributed-by-two-leading-companies
Immun oncology therapies are going to be commerzialized and sitributed by two leading companies
Bristol-Myers Squibb and Five Prime Pharmaceuticals announced a kind of contribution in the frame of which they are going to commercialize and distribute oncology drug. ...
Tags: oncology drug, pharmaceutical companies, Birstol-Myers, Five Prime...
March 20, 2014
UCB-and-Sanofi-started-a-new-partnership
UCB and Sanofi started a new partnership
Belgium-based UCB and Sanofi announced that they entered into a new strategic partnership.The new contract aims to develop treatmens for immune-based diseases in the field of gastroenterology and arthritis....
Tags: Sanofi, UCB , arthritis, gastroenterology...
March 17, 2014
Ludwig-Institute-for-Cancer-Research-and-Agenus-developing-vaccine-together
Ludwig Institute for Cancer Research and Agenus developing vaccine together
The Ludwig Institute for Cancer Research and Agenus are named heir selection of three monoclonal antibody checkpoint modulators. The research is going to be a part of the companies' cacer vaccine project. ...
Tags: Cancer vaccine, antibody, monoclonal antibody checkpoint modulators, Agenus, Ludwig Institute for Cancer Research...
March 10, 2014
Full-consumer-unit-controll-is-going-to-be-bought-by-GSK-in-Indonesia
Full consumer unit controll is going to be bought by GSK in Indonesia
Indonesia is one of the rapidly growing markets that drugmakers are trying to tap to boost sales, and GlaxoSmithKline is going to own the full control of consumer unit. ...
Tags: GSK, indonesia, stock, stocck exchange...
April 2, 2014
Mayroy-sold-approximately-7-of-its-Ipsen-sales
Mayroy sold approximately 7% of its Ipsen sales
Mayroy, the controlling shareholder of Ipsen has announced that it sold almost 8% of its shares via private placement. The total share of Ipsen exceeded to1.2 billion Eros in 2013....
Tags: Mayroy, Ipsen, share, private placement...
March 21, 2014
Charles-River-Laboratories-International-signed-a-new-contract
Charles River Laboratories International signed a new contract
Charles River Laboratories International has entered in a contract with Argenta and BioFocus. This trade is going to be one of the most profitable investments for all the companies....
Tags: Drug discovery, Charles River Laboratories International. BioFocus, Argenta, contract...
March 20, 2014
Start-ups-in-the-fielf-of-Drug-Discovery-are-blossoming
Start-ups in the fielf of Drug Discovery are blossoming
Lilly, Celgene, Sanofi, Roche are pioneers of a new way of grounding companies. Start-ups are now blossoming. The quesiton is how sustainable this technology will prove to be....
Tags: start-up company, Lilly, Celgene, Sanofi, Roche...
March 17, 2014
Novo-Nordisk-expands-its-license-agreement-with-Cassion-Biotech
Novo Nordisk expands its license agreement with Cassion Biotech
The contract between Novo Nordisk and Cssion Biotech is going to guarantee exclusive right for Nordisk to commercialize insulin conjugated to HEPtune. This medicine offers help for inflammatory diseases such as Crohn’s disease, lupus, rheumatoid and psoriatic arthriti...
Tags: inflammatory disease, Crohn’s disease, lupus, rheumatoid arthritis, Novo Nordisk, Nordisk, Cassion, Cassion Biotech...
March 13, 2014
Astra-Zeneca-has-signed-a-contract-with-the-South-Korean-Government
Astra Zeneca has signed a contract with the South Korean Government
A memorandum of understanding was signed by AstraZeneca and South Korean government. Korea guarantees to help some early-stage drug development projects....
Tags: AstraZeneca, research, South Korea, memorandum of understanding...
March 9, 2014
MOST VIEWED

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013